Psychedelics Investing Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities
Psychedelics Investing Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
Psychedelics Investing Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
Psychedelics Investing Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression
Alvopetro Announces an Operational Update, Q1 2025 Financial Results and Details for our Upcoming AGM
Grande Portage Stakes Added Claims to Accommodate Potential Surface Facilities at the New Amalga Gold Project
Blue Lagoon Resources to Showcase Dome Mountain Gold Project at 121 Mining Investment Conference in London
American Salars Starts Sampling at 100% Owned Brazilian LCT Pegmatite Project, with Past Samples Hitting 3.72% Li2o and Significant Ree Values
